nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—SLC22A6—Furosemide—dilated cardiomyopathy	0.207	0.54	CbGbCtD
Flurbiprofen—ALB—Furosemide—dilated cardiomyopathy	0.176	0.46	CbGbCtD
Flurbiprofen—UGT2B4—pericardium—dilated cardiomyopathy	0.0721	0.394	CbGeAlD
Flurbiprofen—CYP2C9—cardial valve—dilated cardiomyopathy	0.0397	0.217	CbGeAlD
Flurbiprofen—UGT2B4—cardiac ventricle—dilated cardiomyopathy	0.017	0.0928	CbGeAlD
Flurbiprofen—UGT2B4—myocardium—dilated cardiomyopathy	0.016	0.0873	CbGeAlD
Flurbiprofen—UGT2B4—heart—dilated cardiomyopathy	0.0111	0.0609	CbGeAlD
Flurbiprofen—UGT2B4—cardiac atrium—dilated cardiomyopathy	0.00953	0.0521	CbGeAlD
Flurbiprofen—Incontinence—Furosemide—dilated cardiomyopathy	0.00906	0.0227	CcSEcCtD
Flurbiprofen—Breast pain—Spironolactone—dilated cardiomyopathy	0.00667	0.0167	CcSEcCtD
Flurbiprofen—Ulcer—Spironolactone—dilated cardiomyopathy	0.00615	0.0154	CcSEcCtD
Flurbiprofen—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00596	0.0149	CcSEcCtD
Flurbiprofen—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00572	0.0143	CcSEcCtD
Flurbiprofen—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.00492	0.0123	CcSEcCtD
Flurbiprofen—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.00469	0.0117	CcSEcCtD
Flurbiprofen—Ear disorder—Lisinopril—dilated cardiomyopathy	0.0044	0.011	CcSEcCtD
Flurbiprofen—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00414	0.0103	CcSEcCtD
Flurbiprofen—Ataxia—Spironolactone—dilated cardiomyopathy	0.00397	0.00994	CcSEcCtD
Flurbiprofen—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.00394	0.00986	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0038	0.00952	CcSEcCtD
Flurbiprofen—Gastritis—Spironolactone—dilated cardiomyopathy	0.00374	0.00936	CcSEcCtD
Flurbiprofen—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00362	0.00905	CcSEcCtD
Flurbiprofen—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.0036	0.00902	CcSEcCtD
Flurbiprofen—ALB—heart—dilated cardiomyopathy	0.00351	0.0192	CbGeAlD
Flurbiprofen—Heartburn—Lisinopril—dilated cardiomyopathy	0.00345	0.00864	CcSEcCtD
Flurbiprofen—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00341	0.00854	CcSEcCtD
Flurbiprofen—Drug interaction—Furosemide—dilated cardiomyopathy	0.00341	0.00854	CcSEcCtD
Flurbiprofen—ABCC4—heart—dilated cardiomyopathy	0.0034	0.0186	CbGeAlD
Flurbiprofen—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00336	0.00842	CcSEcCtD
Flurbiprofen—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00333	0.00832	CcSEcCtD
Flurbiprofen—Laryngitis—Lisinopril—dilated cardiomyopathy	0.0033	0.00825	CcSEcCtD
Flurbiprofen—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00326	0.00815	CcSEcCtD
Flurbiprofen—Vasculitis—Furosemide—dilated cardiomyopathy	0.00324	0.00812	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00323	0.00808	CcSEcCtD
Flurbiprofen—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00322	0.00807	CcSEcCtD
Flurbiprofen—Renal failure—Spironolactone—dilated cardiomyopathy	0.0032	0.00801	CcSEcCtD
Flurbiprofen—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00316	0.0079	CcSEcCtD
Flurbiprofen—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00304	0.0076	CcSEcCtD
Flurbiprofen—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00297	0.00744	CcSEcCtD
Flurbiprofen—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00289	0.0911	CbGpPWpGaD
Flurbiprofen—PTGS1—myocardium—dilated cardiomyopathy	0.00287	0.0157	CbGeAlD
Flurbiprofen—Bladder pain—Furosemide—dilated cardiomyopathy	0.00286	0.00716	CcSEcCtD
Flurbiprofen—Urine output increased—Furosemide—dilated cardiomyopathy	0.00286	0.00716	CcSEcCtD
Flurbiprofen—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00276	0.00692	CcSEcCtD
Flurbiprofen—Breast pain—Lisinopril—dilated cardiomyopathy	0.00272	0.00681	CcSEcCtD
Flurbiprofen—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.0027	0.00677	CcSEcCtD
Flurbiprofen—Proteinuria—Lisinopril—dilated cardiomyopathy	0.0027	0.00677	CcSEcCtD
Flurbiprofen—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00267	0.00667	CcSEcCtD
Flurbiprofen—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00262	0.00655	CcSEcCtD
Flurbiprofen—Polyuria—Furosemide—dilated cardiomyopathy	0.00262	0.00655	CcSEcCtD
Flurbiprofen—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00261	0.00654	CcSEcCtD
Flurbiprofen—Cough increased—Lisinopril—dilated cardiomyopathy	0.0026	0.00649	CcSEcCtD
Flurbiprofen—Alopecia—Spironolactone—dilated cardiomyopathy	0.00258	0.00646	CcSEcCtD
Flurbiprofen—Oliguria—Lisinopril—dilated cardiomyopathy	0.00258	0.00645	CcSEcCtD
Flurbiprofen—Deafness—Furosemide—dilated cardiomyopathy	0.00257	0.00643	CcSEcCtD
Flurbiprofen—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00257	0.00643	CcSEcCtD
Flurbiprofen—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00256	0.00641	CcSEcCtD
Flurbiprofen—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00255	0.00637	CcSEcCtD
Flurbiprofen—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00253	0.00633	CcSEcCtD
Flurbiprofen—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00244	0.0061	CcSEcCtD
Flurbiprofen—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00243	0.00609	CcSEcCtD
Flurbiprofen—Thirst—Furosemide—dilated cardiomyopathy	0.00242	0.00604	CcSEcCtD
Flurbiprofen—Purpura—Furosemide—dilated cardiomyopathy	0.00238	0.00597	CcSEcCtD
Flurbiprofen—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00238	0.00595	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00236	0.00591	CcSEcCtD
Flurbiprofen—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00233	0.00584	CcSEcCtD
Flurbiprofen—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00232	0.00581	CcSEcCtD
Flurbiprofen—Malaise—Spironolactone—dilated cardiomyopathy	0.00229	0.00574	CcSEcCtD
Flurbiprofen—Cystitis—Lisinopril—dilated cardiomyopathy	0.00229	0.00574	CcSEcCtD
Flurbiprofen—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00228	0.0057	CcSEcCtD
Flurbiprofen—Photophobia—Lisinopril—dilated cardiomyopathy	0.00223	0.00558	CcSEcCtD
Flurbiprofen—CYP2C9—heart—dilated cardiomyopathy	0.00219	0.012	CbGeAlD
Flurbiprofen—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00215	0.00538	CcSEcCtD
Flurbiprofen—Discomfort—Spironolactone—dilated cardiomyopathy	0.00214	0.00536	CcSEcCtD
Flurbiprofen—Confusional state—Spironolactone—dilated cardiomyopathy	0.00209	0.00524	CcSEcCtD
Flurbiprofen—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00208	0.00521	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00208	0.0052	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00207	0.00518	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00203	0.00509	CcSEcCtD
Flurbiprofen—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00203	0.00507	CcSEcCtD
Flurbiprofen—PTGS1—heart—dilated cardiomyopathy	0.002	0.0109	CbGeAlD
Flurbiprofen—Abdominal distension—Furosemide—dilated cardiomyopathy	0.002	0.005	CcSEcCtD
Flurbiprofen—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00197	0.00492	CcSEcCtD
Flurbiprofen—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00196	0.00492	CcSEcCtD
Flurbiprofen—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00195	0.00487	CcSEcCtD
Flurbiprofen—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00195	0.00487	CcSEcCtD
Flurbiprofen—Eczema—Lisinopril—dilated cardiomyopathy	0.00192	0.0048	CcSEcCtD
Flurbiprofen—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00192	0.0048	CcSEcCtD
Flurbiprofen—PTGS2—heart—dilated cardiomyopathy	0.00191	0.0105	CbGeAlD
Flurbiprofen—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00191	0.00478	CcSEcCtD
Flurbiprofen—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00186	0.00465	CcSEcCtD
Flurbiprofen—Somnolence—Spironolactone—dilated cardiomyopathy	0.00185	0.00462	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00181	0.00454	CcSEcCtD
Flurbiprofen—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00181	0.00453	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00179	0.00448	CcSEcCtD
Flurbiprofen—Arthritis—Lisinopril—dilated cardiomyopathy	0.00177	0.00444	CcSEcCtD
Flurbiprofen—Drowsiness—Furosemide—dilated cardiomyopathy	0.00177	0.00443	CcSEcCtD
Flurbiprofen—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00176	0.0044	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00176	0.00439	CcSEcCtD
Flurbiprofen—Renal failure—Furosemide—dilated cardiomyopathy	0.00174	0.00436	CcSEcCtD
Flurbiprofen—Diplopia—Lisinopril—dilated cardiomyopathy	0.00172	0.00432	CcSEcCtD
Flurbiprofen—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00172	0.00432	CcSEcCtD
Flurbiprofen—PTGS1—cardiac atrium—dilated cardiomyopathy	0.00171	0.00936	CbGeAlD
Flurbiprofen—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00171	0.00428	CcSEcCtD
Flurbiprofen—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00171	0.00428	CcSEcCtD
Flurbiprofen—Sweating—Furosemide—dilated cardiomyopathy	0.0017	0.00425	CcSEcCtD
Flurbiprofen—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00165	0.00414	CcSEcCtD
Flurbiprofen—Urticaria—Spironolactone—dilated cardiomyopathy	0.00165	0.00413	CcSEcCtD
Flurbiprofen—Labetalol—ADRB1—dilated cardiomyopathy	0.00164	0.543	CrCbGaD
Flurbiprofen—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00164	0.00411	CcSEcCtD
Flurbiprofen—Ataxia—Lisinopril—dilated cardiomyopathy	0.00162	0.00406	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00155	0.00389	CcSEcCtD
Flurbiprofen—Visual impairment—Furosemide—dilated cardiomyopathy	0.00153	0.00383	CcSEcCtD
Flurbiprofen—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00153	0.00383	CcSEcCtD
Flurbiprofen—Gastritis—Lisinopril—dilated cardiomyopathy	0.00153	0.00382	CcSEcCtD
Flurbiprofen—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.0015	0.00376	CcSEcCtD
Flurbiprofen—Asthma—Lisinopril—dilated cardiomyopathy	0.00149	0.00373	CcSEcCtD
Flurbiprofen—Influenza—Lisinopril—dilated cardiomyopathy	0.00149	0.00373	CcSEcCtD
Flurbiprofen—Tinnitus—Furosemide—dilated cardiomyopathy	0.00148	0.00371	CcSEcCtD
Flurbiprofen—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00148	0.00369	CcSEcCtD
Flurbiprofen—Pruritus—Spironolactone—dilated cardiomyopathy	0.00147	0.00368	CcSEcCtD
Flurbiprofen—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00146	0.00366	CcSEcCtD
Flurbiprofen—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00145	0.00363	CcSEcCtD
Flurbiprofen—Angiopathy—Furosemide—dilated cardiomyopathy	0.00144	0.00361	CcSEcCtD
Flurbiprofen—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00143	0.00359	CcSEcCtD
Flurbiprofen—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00142	0.00356	CcSEcCtD
Flurbiprofen—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00142	0.00355	CcSEcCtD
Flurbiprofen—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00142	0.00354	CcSEcCtD
Flurbiprofen—Dysuria—Lisinopril—dilated cardiomyopathy	0.00139	0.00349	CcSEcCtD
Flurbiprofen—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00139	0.00349	CcSEcCtD
Flurbiprofen—Labetalol—ADRB2—dilated cardiomyopathy	0.00138	0.457	CrCbGaD
Flurbiprofen—Dizziness—Spironolactone—dilated cardiomyopathy	0.00137	0.00344	CcSEcCtD
Flurbiprofen—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00137	0.00344	CcSEcCtD
Flurbiprofen—ABCC4—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00137	0.0431	CbGpPWpGaD
Flurbiprofen—Flatulence—Furosemide—dilated cardiomyopathy	0.00136	0.00341	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00136	0.0034	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00134	0.00336	CcSEcCtD
Flurbiprofen—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00134	0.00335	CcSEcCtD
Flurbiprofen—Vomiting—Spironolactone—dilated cardiomyopathy	0.00132	0.0033	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00132	0.0033	CcSEcCtD
Flurbiprofen—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00131	0.00328	CcSEcCtD
Flurbiprofen—Rash—Spironolactone—dilated cardiomyopathy	0.00131	0.00328	CcSEcCtD
Flurbiprofen—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00131	0.00327	CcSEcCtD
Flurbiprofen—Renal failure—Lisinopril—dilated cardiomyopathy	0.00131	0.00327	CcSEcCtD
Flurbiprofen—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.0013	0.00326	CcSEcCtD
Flurbiprofen—Headache—Spironolactone—dilated cardiomyopathy	0.0013	0.00326	CcSEcCtD
Flurbiprofen—Jaundice—Lisinopril—dilated cardiomyopathy	0.0013	0.00324	CcSEcCtD
Flurbiprofen—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00129	0.00323	CcSEcCtD
Flurbiprofen—Anaemia—Furosemide—dilated cardiomyopathy	0.00128	0.0032	CcSEcCtD
Flurbiprofen—Sweating—Lisinopril—dilated cardiomyopathy	0.00127	0.00319	CcSEcCtD
Flurbiprofen—Haematuria—Lisinopril—dilated cardiomyopathy	0.00127	0.00317	CcSEcCtD
Flurbiprofen—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00125	0.00314	CcSEcCtD
Flurbiprofen—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00125	0.00312	CcSEcCtD
Flurbiprofen—Vertigo—Furosemide—dilated cardiomyopathy	0.00124	0.00311	CcSEcCtD
Flurbiprofen—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00124	0.0031	CcSEcCtD
Flurbiprofen—Leukopenia—Furosemide—dilated cardiomyopathy	0.00124	0.0031	CcSEcCtD
Flurbiprofen—Nausea—Spironolactone—dilated cardiomyopathy	0.00123	0.00309	CcSEcCtD
Flurbiprofen—Rhinitis—Lisinopril—dilated cardiomyopathy	0.0012	0.00299	CcSEcCtD
Flurbiprofen—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00119	0.00299	CcSEcCtD
Flurbiprofen—Hallucination—Lisinopril—dilated cardiomyopathy	0.00119	0.00297	CcSEcCtD
Flurbiprofen—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00118	0.00296	CcSEcCtD
Flurbiprofen—Dry mouth—Furosemide—dilated cardiomyopathy	0.00115	0.00288	CcSEcCtD
Flurbiprofen—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—dilated cardiomyopathy	0.00115	0.0362	CbGpPWpGaD
Flurbiprofen—Confusional state—Furosemide—dilated cardiomyopathy	0.00114	0.00285	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00113	0.00283	CcSEcCtD
Flurbiprofen—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00113	0.00282	CcSEcCtD
Flurbiprofen—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00111	0.00278	CcSEcCtD
Flurbiprofen—Shock—Furosemide—dilated cardiomyopathy	0.00111	0.00278	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00111	0.00277	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00109	0.00273	CcSEcCtD
Flurbiprofen—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00108	0.00271	CcSEcCtD
Flurbiprofen—Anorexia—Furosemide—dilated cardiomyopathy	0.00108	0.00269	CcSEcCtD
Flurbiprofen—Chills—Lisinopril—dilated cardiomyopathy	0.00107	0.00268	CcSEcCtD
Flurbiprofen—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00107	0.00267	CcSEcCtD
Flurbiprofen—Hypotension—Furosemide—dilated cardiomyopathy	0.00106	0.00264	CcSEcCtD
Flurbiprofen—Alopecia—Lisinopril—dilated cardiomyopathy	0.00105	0.00264	CcSEcCtD
Flurbiprofen—Flatulence—Lisinopril—dilated cardiomyopathy	0.00102	0.00256	CcSEcCtD
Flurbiprofen—Tension—Lisinopril—dilated cardiomyopathy	0.00102	0.00255	CcSEcCtD
Flurbiprofen—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00101	0.00254	CcSEcCtD
Flurbiprofen—Nervousness—Lisinopril—dilated cardiomyopathy	0.00101	0.00252	CcSEcCtD
Flurbiprofen—Somnolence—Furosemide—dilated cardiomyopathy	0.001	0.00251	CcSEcCtD
Flurbiprofen—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000982	0.00246	CcSEcCtD
Flurbiprofen—Tremor—Lisinopril—dilated cardiomyopathy	0.000973	0.00244	CcSEcCtD
Flurbiprofen—Constipation—Furosemide—dilated cardiomyopathy	0.000966	0.00242	CcSEcCtD
Flurbiprofen—Pain—Furosemide—dilated cardiomyopathy	0.000966	0.00242	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000964	0.00241	CcSEcCtD
Flurbiprofen—Anaemia—Lisinopril—dilated cardiomyopathy	0.00096	0.0024	CcSEcCtD
Flurbiprofen—Angioedema—Lisinopril—dilated cardiomyopathy	0.000949	0.00237	CcSEcCtD
Flurbiprofen—Malaise—Lisinopril—dilated cardiomyopathy	0.000937	0.00234	CcSEcCtD
Flurbiprofen—Vertigo—Lisinopril—dilated cardiomyopathy	0.000933	0.00234	CcSEcCtD
Flurbiprofen—Syncope—Lisinopril—dilated cardiomyopathy	0.000931	0.00233	CcSEcCtD
Flurbiprofen—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000931	0.00233	CcSEcCtD
Flurbiprofen—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00093	0.00233	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000924	0.00231	CcSEcCtD
Flurbiprofen—Palpitations—Lisinopril—dilated cardiomyopathy	0.000918	0.0023	CcSEcCtD
Flurbiprofen—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000913	0.00228	CcSEcCtD
Flurbiprofen—Cough—Lisinopril—dilated cardiomyopathy	0.000906	0.00227	CcSEcCtD
Flurbiprofen—Urticaria—Furosemide—dilated cardiomyopathy	0.000898	0.00225	CcSEcCtD
Flurbiprofen—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000893	0.00223	CcSEcCtD
Flurbiprofen—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000893	0.00223	CcSEcCtD
Flurbiprofen—Myalgia—Lisinopril—dilated cardiomyopathy	0.000884	0.00221	CcSEcCtD
Flurbiprofen—Anxiety—Lisinopril—dilated cardiomyopathy	0.000881	0.00221	CcSEcCtD
Flurbiprofen—Discomfort—Lisinopril—dilated cardiomyopathy	0.000874	0.00219	CcSEcCtD
Flurbiprofen—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000865	0.00216	CcSEcCtD
Flurbiprofen—Confusional state—Lisinopril—dilated cardiomyopathy	0.000855	0.00214	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000848	0.00212	CcSEcCtD
Flurbiprofen—Oedema—Lisinopril—dilated cardiomyopathy	0.000848	0.00212	CcSEcCtD
Flurbiprofen—Infection—Lisinopril—dilated cardiomyopathy	0.000842	0.00211	CcSEcCtD
Flurbiprofen—Shock—Lisinopril—dilated cardiomyopathy	0.000834	0.00209	CcSEcCtD
Flurbiprofen—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000832	0.00208	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00083	0.00208	CcSEcCtD
Flurbiprofen—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000827	0.00207	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000819	0.00205	CcSEcCtD
Flurbiprofen—Asthenia—Furosemide—dilated cardiomyopathy	0.000811	0.00203	CcSEcCtD
Flurbiprofen—Anorexia—Lisinopril—dilated cardiomyopathy	0.000808	0.00202	CcSEcCtD
Flurbiprofen—Pruritus—Furosemide—dilated cardiomyopathy	0.000799	0.002	CcSEcCtD
Flurbiprofen—ABCC4—Platelet degranulation—TTN—dilated cardiomyopathy	0.000798	0.0252	CbGpPWpGaD
Flurbiprofen—Hypotension—Lisinopril—dilated cardiomyopathy	0.000792	0.00198	CcSEcCtD
Flurbiprofen—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000773	0.00193	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000772	0.00193	CcSEcCtD
Flurbiprofen—Insomnia—Lisinopril—dilated cardiomyopathy	0.000767	0.00192	CcSEcCtD
Flurbiprofen—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000761	0.0019	CcSEcCtD
Flurbiprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.000761	0.024	CbGpPWpGaD
Flurbiprofen—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000756	0.00189	CcSEcCtD
Flurbiprofen—Somnolence—Lisinopril—dilated cardiomyopathy	0.000754	0.00189	CcSEcCtD
Flurbiprofen—UGT1A9—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.000751	0.0236	CbGpPWpGaD
Flurbiprofen—Dizziness—Furosemide—dilated cardiomyopathy	0.000747	0.00187	CcSEcCtD
Flurbiprofen—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000746	0.00187	CcSEcCtD
Flurbiprofen—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000737	0.00184	CcSEcCtD
Flurbiprofen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.000735	0.0231	CbGpPWpGaD
Flurbiprofen—Constipation—Lisinopril—dilated cardiomyopathy	0.000725	0.00181	CcSEcCtD
Flurbiprofen—Pain—Lisinopril—dilated cardiomyopathy	0.000725	0.00181	CcSEcCtD
Flurbiprofen—Vomiting—Furosemide—dilated cardiomyopathy	0.000718	0.0018	CcSEcCtD
Flurbiprofen—Rash—Furosemide—dilated cardiomyopathy	0.000712	0.00178	CcSEcCtD
Flurbiprofen—Dermatitis—Furosemide—dilated cardiomyopathy	0.000712	0.00178	CcSEcCtD
Flurbiprofen—Headache—Furosemide—dilated cardiomyopathy	0.000708	0.00177	CcSEcCtD
Flurbiprofen—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000699	0.00175	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000693	0.00173	CcSEcCtD
Flurbiprofen—ABCC4—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000692	0.0218	CbGpPWpGaD
Flurbiprofen—Urticaria—Lisinopril—dilated cardiomyopathy	0.000673	0.00169	CcSEcCtD
Flurbiprofen—Nausea—Furosemide—dilated cardiomyopathy	0.000671	0.00168	CcSEcCtD
Flurbiprofen—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00067	0.00168	CcSEcCtD
Flurbiprofen—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00067	0.00168	CcSEcCtD
Flurbiprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000659	0.0208	CbGpPWpGaD
Flurbiprofen—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000625	0.00156	CcSEcCtD
Flurbiprofen—Asthenia—Lisinopril—dilated cardiomyopathy	0.000608	0.00152	CcSEcCtD
Flurbiprofen—Pruritus—Lisinopril—dilated cardiomyopathy	0.0006	0.0015	CcSEcCtD
Flurbiprofen—ABCC4—Platelet degranulation—VCL—dilated cardiomyopathy	0.000589	0.0185	CbGpPWpGaD
Flurbiprofen—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00058	0.00145	CcSEcCtD
Flurbiprofen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00058	0.0183	CbGpPWpGaD
Flurbiprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000561	0.0177	CbGpPWpGaD
Flurbiprofen—Dizziness—Lisinopril—dilated cardiomyopathy	0.000561	0.0014	CcSEcCtD
Flurbiprofen—Vomiting—Lisinopril—dilated cardiomyopathy	0.000539	0.00135	CcSEcCtD
Flurbiprofen—Rash—Lisinopril—dilated cardiomyopathy	0.000534	0.00134	CcSEcCtD
Flurbiprofen—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000534	0.00134	CcSEcCtD
Flurbiprofen—Headache—Lisinopril—dilated cardiomyopathy	0.000531	0.00133	CcSEcCtD
Flurbiprofen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.000506	0.0159	CbGpPWpGaD
Flurbiprofen—Nausea—Lisinopril—dilated cardiomyopathy	0.000504	0.00126	CcSEcCtD
Flurbiprofen—PTGS2—S1P1 pathway—RAC1—dilated cardiomyopathy	0.00042	0.0132	CbGpPWpGaD
Flurbiprofen—ABCC4—Ectoderm Differentiation—DMD—dilated cardiomyopathy	0.000391	0.0123	CbGpPWpGaD
Flurbiprofen—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.000361	0.0114	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000354	0.0112	CbGpPWpGaD
Flurbiprofen—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.000344	0.0108	CbGpPWpGaD
Flurbiprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—dilated cardiomyopathy	0.000316	0.00997	CbGpPWpGaD
Flurbiprofen—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000313	0.00987	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000307	0.00967	CbGpPWpGaD
Flurbiprofen—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000298	0.0094	CbGpPWpGaD
Flurbiprofen—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.000266	0.00839	CbGpPWpGaD
Flurbiprofen—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000266	0.00837	CbGpPWpGaD
Flurbiprofen—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000263	0.0083	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000261	0.00823	CbGpPWpGaD
Flurbiprofen—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000254	0.00799	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet degranulation—CD36—dilated cardiomyopathy	0.000252	0.00794	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000243	0.00764	CbGpPWpGaD
Flurbiprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.00024	0.00756	CbGpPWpGaD
Flurbiprofen—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000229	0.00721	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—TAZ—dilated cardiomyopathy	0.000228	0.00718	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000219	0.00691	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000217	0.00682	CbGpPWpGaD
Flurbiprofen—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000211	0.00664	CbGpPWpGaD
Flurbiprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.00021	0.00663	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—SDHA—dilated cardiomyopathy	0.000206	0.0065	CbGpPWpGaD
Flurbiprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.000205	0.00645	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000202	0.00635	CbGpPWpGaD
Flurbiprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.0002	0.00631	CbGpPWpGaD
Flurbiprofen—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.000195	0.00613	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00019	0.00597	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—TTN—dilated cardiomyopathy	0.000183	0.00575	CbGpPWpGaD
Flurbiprofen—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000182	0.00572	CbGpPWpGaD
Flurbiprofen—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000177	0.00558	CbGpPWpGaD
Flurbiprofen—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000176	0.00554	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.000172	0.00542	CbGpPWpGaD
Flurbiprofen—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000169	0.00532	CbGpPWpGaD
Flurbiprofen—UGT1A9—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000169	0.00532	CbGpPWpGaD
Flurbiprofen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000165	0.00521	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000164	0.00518	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00016	0.00505	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—ACTN2—dilated cardiomyopathy	0.000158	0.00499	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000158	0.00498	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000154	0.00487	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000154	0.00484	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000154	0.00484	CbGpPWpGaD
Flurbiprofen—UGT1A9—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000152	0.00479	CbGpPWpGaD
Flurbiprofen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000149	0.00469	CbGpPWpGaD
Flurbiprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000145	0.00458	CbGpPWpGaD
Flurbiprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000145	0.00458	CbGpPWpGaD
Flurbiprofen—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000143	0.00451	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000143	0.0045	CbGpPWpGaD
Flurbiprofen—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000141	0.00443	CbGpPWpGaD
Flurbiprofen—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00014	0.0044	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000139	0.00438	CbGpPWpGaD
Flurbiprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000138	0.00436	CbGpPWpGaD
Flurbiprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000138	0.00436	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000138	0.00433	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000137	0.00432	CbGpPWpGaD
Flurbiprofen—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000137	0.00431	CbGpPWpGaD
Flurbiprofen—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000137	0.0043	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—VCL—dilated cardiomyopathy	0.000135	0.00424	CbGpPWpGaD
Flurbiprofen—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000134	0.00423	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000134	0.00422	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000134	0.00422	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00013	0.00411	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00013	0.00409	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.000128	0.00402	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000124	0.00392	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000123	0.00386	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—TAZ—dilated cardiomyopathy	0.000122	0.00385	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000118	0.00372	CbGpPWpGaD
Flurbiprofen—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000114	0.00359	CbGpPWpGaD
Flurbiprofen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000114	0.00359	CbGpPWpGaD
Flurbiprofen—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000114	0.00358	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000112	0.00352	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—ANKRD1—dilated cardiomyopathy	0.00011	0.00348	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—SDHA—dilated cardiomyopathy	0.00011	0.00348	CbGpPWpGaD
Flurbiprofen—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000109	0.00342	CbGpPWpGaD
Flurbiprofen—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000109	0.00342	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000106	0.00332	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000105	0.00332	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—TAZ—dilated cardiomyopathy	0.000104	0.00327	CbGpPWpGaD
Flurbiprofen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000103	0.00323	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.92e-05	0.00313	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	9.73e-05	0.00307	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	9.4e-05	0.00296	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—SDHA—dilated cardiomyopathy	9.39e-05	0.00296	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—ANKRD1—dilated cardiomyopathy	8.98e-05	0.00283	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—ANKRD1—dilated cardiomyopathy	8.98e-05	0.00283	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	8.96e-05	0.00282	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.64e-05	0.00272	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—TAZ—dilated cardiomyopathy	8.44e-05	0.00266	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—TAZ—dilated cardiomyopathy	8.44e-05	0.00266	CbGpPWpGaD
Flurbiprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	8.38e-05	0.00264	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TTN—dilated cardiomyopathy	8.26e-05	0.0026	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	8.12e-05	0.00256	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—SDHA—dilated cardiomyopathy	7.63e-05	0.0024	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—SDHA—dilated cardiomyopathy	7.63e-05	0.0024	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	7.32e-05	0.00231	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	7.16e-05	0.00226	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.15e-05	0.00225	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	7e-05	0.00221	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	6.99e-05	0.0022	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.96e-05	0.00219	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.96e-05	0.00219	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	6.88e-05	0.00217	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—ITGB1—dilated cardiomyopathy	6.76e-05	0.00213	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	6.75e-05	0.00213	CbGpPWpGaD
Flurbiprofen—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	6.71e-05	0.00212	CbGpPWpGaD
Flurbiprofen—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	6.67e-05	0.0021	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	6.62e-05	0.00209	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.47e-05	0.00204	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	6.22e-05	0.00196	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—VCL—dilated cardiomyopathy	6.09e-05	0.00192	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	5.81e-05	0.00183	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—CD36—dilated cardiomyopathy	5.76e-05	0.00182	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—GPX1—dilated cardiomyopathy	5.6e-05	0.00177	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	5.46e-05	0.00172	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—CD36—dilated cardiomyopathy	5.46e-05	0.00172	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—RAC1—dilated cardiomyopathy	5.43e-05	0.00171	CbGpPWpGaD
Flurbiprofen—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	5.43e-05	0.00171	CbGpPWpGaD
Flurbiprofen—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	5.33e-05	0.00168	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	5.06e-05	0.00159	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	4.94e-05	0.00156	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—AGT—dilated cardiomyopathy	4.91e-05	0.00155	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	4.77e-05	0.0015	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	4.7e-05	0.00148	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.66e-05	0.00147	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.53e-05	0.00143	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	4.43e-05	0.00139	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—TAZ—dilated cardiomyopathy	4.42e-05	0.00139	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.39e-05	0.00138	CbGpPWpGaD
Flurbiprofen—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	4.31e-05	0.00136	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	4.22e-05	0.00133	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.08e-05	0.00129	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—SDHA—dilated cardiomyopathy	4e-05	0.00126	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	3.85e-05	0.00121	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.8e-05	0.0012	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.7e-05	0.00116	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	3.62e-05	0.00114	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—RAF1—dilated cardiomyopathy	3.6e-05	0.00113	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.33e-05	0.00105	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	3.27e-05	0.00103	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	3.16e-05	0.000996	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.12e-05	0.000982	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	3.06e-05	0.000963	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NPPA—dilated cardiomyopathy	3.02e-05	0.000951	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.01e-05	0.000949	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.01e-05	0.000949	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—GPX1—dilated cardiomyopathy	3e-05	0.000945	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.93e-05	0.000924	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PSEN2—dilated cardiomyopathy	2.92e-05	0.000921	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—CD36—dilated cardiomyopathy	2.92e-05	0.000921	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.87e-05	0.000903	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.71e-05	0.000855	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.64e-05	0.000832	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—AGT—dilated cardiomyopathy	2.63e-05	0.000829	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—CD36—dilated cardiomyopathy	2.61e-05	0.000822	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—GPX1—dilated cardiomyopathy	2.55e-05	0.000804	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CD36—dilated cardiomyopathy	2.49e-05	0.000783	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—RAC1—dilated cardiomyopathy	2.46e-05	0.000774	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.44e-05	0.000768	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.37e-05	0.000748	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—AGT—dilated cardiomyopathy	2.24e-05	0.000705	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.14e-05	0.000673	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GPX1—dilated cardiomyopathy	2.07e-05	0.000653	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GPX1—dilated cardiomyopathy	2.07e-05	0.000653	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CD36—dilated cardiomyopathy	2.02e-05	0.000636	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CD36—dilated cardiomyopathy	2.02e-05	0.000636	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2e-05	0.000629	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.94e-05	0.000612	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—AGT—dilated cardiomyopathy	1.82e-05	0.000573	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—AGT—dilated cardiomyopathy	1.82e-05	0.000573	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.75e-05	0.000551	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	1.69e-05	0.000533	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CD36—dilated cardiomyopathy	1.65e-05	0.000519	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—RAF1—dilated cardiomyopathy	1.63e-05	0.000513	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—AGT—dilated cardiomyopathy	1.48e-05	0.000467	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—RAC1—dilated cardiomyopathy	1.47e-05	0.000463	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.41e-05	0.000444	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	1.34e-05	0.000423	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CD36—dilated cardiomyopathy	1.31e-05	0.000412	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—AGT—dilated cardiomyopathy	1.18e-05	0.000371	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GPX1—dilated cardiomyopathy	1.09e-05	0.000342	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CD36—dilated cardiomyopathy	1.06e-05	0.000333	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—RAF1—dilated cardiomyopathy	9.75e-06	0.000307	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—AGT—dilated cardiomyopathy	9.52e-06	0.0003	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	8.89e-06	0.00028	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	8.65e-06	0.000273	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	7.79e-06	0.000245	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EGFR—dilated cardiomyopathy	6.69e-06	0.000211	CbGpPWpGaD
